世界のベンダムスチン市場レポート2020年

【英語タイトル】Global Bendamustine Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB1753)・商品コード:QYR21FB1753
・発行会社(調査会社):QYResearch
・発行日:2021年1月
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥512,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥768,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,024,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のベンダムスチン市場について種類別(25mg注射、100mg注射、その他)、用途別(慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ベンダムスチン市場の概要
・世界の主要地域別ベンダムスチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のベンダムスチン市場規模2015-2026:種類別(25mg注射、100mg注射、その他)
・世界のベンダムスチン市場規模2015-2026:用途別(慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫)
・ベンダムスチンのアメリカ市場規模2015-2020
・ベンダムスチンのヨーロッパ市場規模2015-2020
・ベンダムスチンの中国市場規模2015-2020
・ベンダムスチンの日本市場規模2015-2020
・ベンダムスチンの東南アジア市場規模2015-2020
・ベンダムスチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ベンダムスチンの製造コスト分析
・販売チャネル、流通業者、顧客
・ベンダムスチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin’s lymphoma. It is given by injection into a vein.
Market competition is intense. Teva, Eisai, Eagle Pharmaceuticals, MundiPharma, Mylan, Natco Pharma, Emcure, etc. are the leaders of the industry, with Teva occupies the major markets share of over 83% in 2018.

Market Analysis and Insights: Global Bendamustine Market
The global Bendamustine market size is projected to reach US$ 757.3 million by 2026, from US$ 799.5 million in 2020, at a CAGR of -0.9% during 2021-2026.

Global Bendamustine Scope and Market Size
The global Bendamustine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bendamustine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Bendamustine market is segmented into
25mg Injection
100mg Injection
Others
The classification of Bendamustine includes 25mg injection, 100mg injection and other and the proportion of 25mg injection in 2018 is about 64.9%.

Segment by Application, the Bendamustine market is segmented into
Chronic Lymphocytic Leukemia
Multiple Myeloma
Non-Hodgkin’s Lymphoma
The proportion used in Non-Hodgkin’s Lymphoma occupied the major market share, with about 44.5% in 2018.

The Bendamustine market is analysed and market size information is provided by regions (countries). Segment by Application, the Bendamustine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Bendamustine Market Share Analysis
Bendamustine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bendamustine business, the date to enter into the Bendamustine market, Bendamustine product introduction, recent developments, etc.

The major vendors covered:
Teva
Eisai
Eagle Pharmaceuticals
MundiPharma
Mylan
Natco Pharma
Emcure
Miracalus Pharma

【レポートの目次】

1 Bendamustine Market Overview
1.1 Bendamustine Product Scope
1.2 Bendamustine Segment by Type
1.2.1 Global Bendamustine Sales by Type (2020-2026)
1.2.2 25mg Injection
1.2.3 100mg Injection
1.2.4 Others
1.3 Bendamustine Segment by Application
1.3.1 Global Bendamustine Sales Comparison by Application (2020-2026)
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Multiple Myeloma
1.3.4 Non-Hodgkin’s Lymphoma
1.4 Bendamustine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Bendamustine Sales Growth Rate (2015-2026)
1.4.2 Global Bendamustine Revenue and Growth Rate (2015-2026)
1.4.3 Global Bendamustine Price Trends (2015-2026)

2 Bendamustine Estimate and Forecast by Region
2.1 Global Bendamustine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Bendamustine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Bendamustine Sales Market Share by Region (2015-2020)
2.2.2 Global Bendamustine Revenue Market Share by Region (2015-2020)
2.3 Global Bendamustine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Bendamustine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Bendamustine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Bendamustine Estimates and Projections (2015-2026)
2.4.2 Europe Bendamustine Estimates and Projections (2015-2026)
2.4.3 China Bendamustine Estimates and Projections (2015-2026)
2.4.4 Japan Bendamustine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Bendamustine Estimates and Projections (2015-2026)
2.4.6 India Bendamustine Estimates and Projections (2015-2026)
3 Global Bendamustine Competition Landscape by Players
3.1 Global Top Bendamustine Players by Sales (2015-2020)
3.2 Global Top Bendamustine Players by Revenue (2015-2020)
3.3 Global Bendamustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bendamustine as of 2019)
3.4 Global Bendamustine Average Price by Company (2015-2020)
3.5 Manufacturers Bendamustine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Bendamustine Players (Opinion Leaders)
4 Global Bendamustine Market Size by Type
4.1 Global Bendamustine Historic Market Review by Type (2015-2020)
4.1.1 Global Bendamustine Sales Market Share by Type (2015-2020)
4.1.2 Global Bendamustine Revenue Market Share by Type (2015-2020)
4.1.3 Global Bendamustine Price by Type (2015-2020)
4.2 Global Bendamustine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Bendamustine Sales Forecast by Type (2021-2026)
4.2.2 Global Bendamustine Revenue Forecast by Type (2021-2026)
4.2.3 Global Bendamustine Price Forecast by Type (2021-2026)
5 Global Bendamustine Market Size by Application
5.1 Global Bendamustine Historic Market Review by Application (2015-2020)
5.1.1 Global Bendamustine Sales Market Share by Application (2015-2020)
5.1.2 Global Bendamustine Revenue Market Share by Application (2015-2020)
5.1.3 Global Bendamustine Price by Application (2015-2020)
5.2 Global Bendamustine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Bendamustine Sales Forecast by Application (2021-2026)
5.2.2 Global Bendamustine Revenue Forecast by Application (2021-2026)
5.2.3 Global Bendamustine Price Forecast by Application (2021-2026)

6 United States Bendamustine Market Facts & Figures
6.1 United States Bendamustine Sales Market Share by Company (2015-2020)
6.2 United States Bendamustine Sales Market Share by Type (2015-2020)
6.3 United States Bendamustine Sales Market Share by Application (2015-2020)

7 Europe Bendamustine Market Facts & Figures
7.1 Europe Bendamustine Sales Market Share by Company (2015-2020)
7.2 Europe Bendamustine Sales Market Share by Type (2015-2020)
7.3 Europe Bendamustine Sales Market Share by Application (2015-2020)

8 China Bendamustine Market Facts & Figures
8.1 China Bendamustine Sales Market Share by Company (2015-2020)
8.2 China Bendamustine Sales Market Share by Type (2015-2020)
8.3 China Bendamustine Sales Market Share by Application (2015-2020)

9 Japan Bendamustine Market Facts & Figures
9.1 Japan Bendamustine Sales Market Share by Company (3015-3030)
9.2 Japan Bendamustine Sales Market Share by Type (2015-2020)
9.3 Japan Bendamustine Sales Market Share by Application (2015-2020)

10 Southeast Asia Bendamustine Market Facts & Figures
10.1 Southeast Asia Bendamustine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Bendamustine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Bendamustine Sales Market Share by Application (2015-2020)

11 India Bendamustine Market Facts & Figures
11.1 India Bendamustine Sales Market Share by Company (2015-2020)
11.2 India Bendamustine Sales Market Share by Type (2015-2020)
11.3 India Bendamustine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Bendamustine Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Bendamustine Products Offered
12.1.5 Teva Recent Development
12.2 Eisai
12.2.1 Eisai Corporation Information
12.2.2 Eisai Business Overview
12.2.3 Eisai Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eisai Bendamustine Products Offered
12.2.5 Eisai Recent Development
12.3 Eagle Pharmaceuticals
12.3.1 Eagle Pharmaceuticals Corporation Information
12.3.2 Eagle Pharmaceuticals Business Overview
12.3.3 Eagle Pharmaceuticals Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eagle Pharmaceuticals Bendamustine Products Offered
12.3.5 Eagle Pharmaceuticals Recent Development
12.4 MundiPharma
12.4.1 MundiPharma Corporation Information
12.4.2 MundiPharma Business Overview
12.4.3 MundiPharma Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 MundiPharma Bendamustine Products Offered
12.4.5 MundiPharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Bendamustine Products Offered
12.5.5 Mylan Recent Development
12.6 Natco Pharma
12.6.1 Natco Pharma Corporation Information
12.6.2 Natco Pharma Business Overview
12.6.3 Natco Pharma Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Natco Pharma Bendamustine Products Offered
12.6.5 Natco Pharma Recent Development
12.7 Emcure
12.7.1 Emcure Corporation Information
12.7.2 Emcure Business Overview
12.7.3 Emcure Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Emcure Bendamustine Products Offered
12.7.5 Emcure Recent Development
12.8 Miracalus Pharma
12.8.1 Miracalus Pharma Corporation Information
12.8.2 Miracalus Pharma Business Overview
12.8.3 Miracalus Pharma Bendamustine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Miracalus Pharma Bendamustine Products Offered
12.8.5 Miracalus Pharma Recent Development

13 Bendamustine Manufacturing Cost Analysis
13.1 Bendamustine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bendamustine
13.4 Bendamustine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bendamustine Distributors List
14.3 Bendamustine Customers

15 Market Dynamics
15.1 Bendamustine Market Trends
15.2 Bendamustine Opportunities and Drivers
15.3 Bendamustine Market Challenges
15.4 Bendamustine Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Bendamustine Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Bendamustine Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Bendamustine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Bendamustine Sales (K Units) by Region (2015-2020)
Table 5. Global Bendamustine Sales Market Share by Region (2015-2020)
Table 6. Global Bendamustine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Bendamustine Revenue Share by Region (2015-2020)
Table 8. Global Bendamustine Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Bendamustine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Bendamustine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Bendamustine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Bendamustine (K Units) of Key Companies (2015-2020)
Table 13. Global Bendamustine Sales Share by Company (2015-2020)
Table 14. Global Bendamustine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Bendamustine Revenue Share by Company (2015-2020)
Table 16. Global Bendamustine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bendamustine as of 2019)
Table 17. Global Bendamustine Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Bendamustine Manufacturing Sites and Area Served
Table 19. Manufacturers Bendamustine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Bendamustine Players
Table 22. Global Bendamustine Sales (K Units) by Type (2015-2020)
Table 23. Global Bendamustine Sales Share by Type (2015-2020)
Table 24. Global Bendamustine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Bendamustine Price (K Units) by Type (2015-2020)
Table 26. Global Bendamustine Sales Share by Type (2021-2026)
Table 27. Global Bendamustine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Bendamustine Revenue Share by Type (2021-2026)
Table 29. Global Bendamustine Price (K Units) by Type (2021-2026)
Table 30. Global Bendamustine Sales (K Units) by Application (2015-2020)
Table 31. Global Bendamustine Sales Share by Application (2015-2020)
Table 32. Global Bendamustine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Bendamustine Price (K Units) by Application (2015-2020)
Table 34. Global Bendamustine Sales (K Units) by Application (2021-2026)
Table 35. Global Bendamustine Sales Share by Application (2021-2026)
Table 36. Global Bendamustine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Bendamustine Revenue Share by Application (2021-2026)
Table 38. Global Bendamustine Price (K Units) by Application (2021-2026)
Table 39. United States Bendamustine Sales (K Units) by Company (2015-2020)
Table 40. United States Bendamustine Sales Market Share by Company (2015-2020)
Table 41. United States Bendamustine Sales (K Units) by Type (2015-2020)
Table 42. United States Bendamustine Sales Market Share by Type (2015-2020)
Table 43. United States Bendamustine Sales (K Units) by Application (2015-2020)
Table 44. United States Bendamustine Sales Market Share by Application (2015-2020)
Table 45. Europe Bendamustine Sales (K Units) by Company (2015-2020)
Table 46. Europe Bendamustine Sales Market Share by Company (2015-2020)
Table 47. Europe Bendamustine Sales (K Units) by Type (2015-2020)
Table 48. Europe Bendamustine Sales Market Share by Type (2015-2020)
Table 49. Europe Bendamustine Sales (K Units) by Application (2015-2020)
Table 50. Europe Bendamustine Sales Market Share by Type (2015-2020)
Table 51. China Bendamustine Sales (K Units) by Company (2015-2020)
Table 52. China Bendamustine Sales Market Share by Company (2015-2020)
Table 53. China Bendamustine Sales (K Units) by Type (2015-2020)
Table 54. China Bendamustine Sales Market Share by Type (2015-2020)
Table 55. China Bendamustine Sales (K Units) by Application (2015-2020)
Table 56. China Bendamustine Sales Market Share by Application (2015-2020)
Table 57. Japan Bendamustine Sales (K Units) by Company (2015-2020)
Table 58. Japan Bendamustine Sales Market Share by Company (2015-2020)
Table 59. Japan Bendamustine Sales (K Units) by Type (2015-2020)
Table 60. Japan Bendamustine Sales Market Share by Type (2015-2020)
Table 61. Japan Bendamustine Sales (K Units) by Application (2015-2020)
Table 62. Japan Bendamustine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Bendamustine Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Bendamustine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Bendamustine Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Bendamustine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Bendamustine Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Bendamustine Sales Market Share by Application (2015-2020)
Table 69. India Bendamustine Sales (K Units) by Company (2015-2020)
Table 70. India Bendamustine Sales Market Share by Company (2015-2020)
Table 71. India Bendamustine Sales (K Units) by Type (2015-2020)
Table 72. India Bendamustine Sales Market Share by Type (2015-2020)
Table 73. India Bendamustine Sales (K Units) by Application (2015-2020)
Table 74. India Bendamustine Sales Market Share by Application (2015-2020)
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Teva Bendamustine Product
Table 79. Teva Recent Development
Table 80. Eisai Corporation Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eisai Bendamustine Product
Table 84. Eisai Recent Development
Table 85. Eagle Pharmaceuticals Corporation Information
Table 86. Eagle Pharmaceuticals Description and Business Overview
Table 87. Eagle Pharmaceuticals Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eagle Pharmaceuticals Bendamustine Product
Table 89. Eagle Pharmaceuticals Recent Development
Table 90. MundiPharma Corporation Information
Table 91. MundiPharma Description and Business Overview
Table 92. MundiPharma Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. MundiPharma Bendamustine Product
Table 94. MundiPharma Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Mylan Bendamustine Product
Table 99. Mylan Recent Development
Table 100. Natco Pharma Corporation Information
Table 101. Natco Pharma Description and Business Overview
Table 102. Natco Pharma Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Natco Pharma Bendamustine Product
Table 104. Natco Pharma Recent Development
Table 105. Emcure Corporation Information
Table 106. Emcure Description and Business Overview
Table 107. Emcure Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Emcure Bendamustine Product
Table 109. Emcure Recent Development
Table 110. Miracalus Pharma Corporation Information
Table 111. Miracalus Pharma Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Miracalus Pharma Description and Business Overview
Table 113. Miracalus Pharma Bendamustine Product
Table 114. Miracalus Pharma Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Bendamustine Distributors List
Table 118. Bendamustine Customers List
Table 119. Bendamustine Market Key Trends
Table 120. Bendamustine Key Opportunities and Drivers
Table 121. Bendamustine Market Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Bendamustine Product Picture
Figure 2. Global Bendamustine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bendamustine Market Share by Application in 2020 & 2026
Figure 6. Chronic Lymphocytic Leukemia Examples
Figure 7. Multiple Myeloma Examples
Figure 8. Non-Hodgkin's Lymphoma Examples
Figure 9. Global Bendamustine Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Bendamustine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Bendamustine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Bendamustine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Bendamustine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Bendamustine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Bendamustine Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Bendamustine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Bendamustine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Bendamustine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Bendamustine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Bendamustine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Bendamustine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Bendamustine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Bendamustine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Bendamustine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Bendamustine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Bendamustine Players Market Share by Revenue in Bendamustine 2015 & 2019
Figure 27. Bendamustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Bendamustine Revenue Share by Type (2015-2020)
Figure 29. Global Bendamustine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Bendamustine Revenue Share by Application (2015-2020)
Figure 31. Global Bendamustine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Bendamustine Sales Market Share by Type in 2019
Figure 33. United States Bendamustine Sales Market Share by Type in 2019
Figure 34. Europe Bendamustine Sales Market Share by Company in 2019
Figure 35. Europe Bendamustine Sales Market Share by Type in 2019
Figure 36. Europe Bendamustine Sales Market Share by Application in 2019
Figure 37. China Bendamustine Sales Market Share by Company in 2019
Figure 38. China Bendamustine Sales Market Share by Type in 2019
Figure 39. China Bendamustine Sales Market Share by Application in 2019
Figure 40. Japan Bendamustine Sales Market Share by Company in 2019
Figure 41. Japan Bendamustine Sales Market Share by Type in 2019
Figure 42. Japan Bendamustine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Bendamustine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Bendamustine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Bendamustine Sales Market Share by Application in 2019
Figure 46. India Bendamustine Sales Market Share by Company in 2019
Figure 47. India Bendamustine Sales Market Share by Type in 2019
Figure 48. India Bendamustine Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Bendamustine
Figure 51. Manufacturing Process Analysis of Bendamustine
Figure 52. Bendamustine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


【掲載企業】

Teva、Eisai、Eagle Pharmaceuticals、MundiPharma、Mylan、Natco Pharma、Emcure、Miracalus Pharma

★調査レポート[世界のベンダムスチン市場レポート2020年] (コード:QYR21FB1753)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のベンダムスチン市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆